(Q34413500)

2 August 2017

1 reference

title

Nilutamide: an antiandrogen for the treatment of prostate cancer (English)

1 reference

2 August 2017

1 reference

E J Dole

1

1 reference

PubMed ID

8997470

2 August 2017

M T Holdsworth

series ordinal

2

1 reference

PubMed ID

8997470

2 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Annals of Pharmacotherapy

2 August 2017

1 reference

2 August 2017

31

1 reference

2 August 2017

1

1 reference

2 August 2017

65-75

1 reference

2 August 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Management of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Current Status of Bilateral Adrenalectomy or Advanced Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Effect of very high dose D-leucine6-gonadotropin-releasing hormone proethylamide on the hypothalamic-pituitary testicular axis in patients with prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Endocrine therapy of advanced carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Antiandrogenic agents as monotherapy in advanced prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Inhibition of Basal and Adrenocorticotropin-Stimulated Plasma Levels of Adrenal Androgens after Treatment with an Antiandrogen in Castrated Patients with Prostatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Pharmacology of antiandrogens and value of combining androgen suppression with antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Pharmacokinetics and metabolism of nilutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg Dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Design of antiandrogens and their mechanisms of action: a case study (anandron).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

The pharmacokinetics of Casodex enantiomers in subjects with impaired liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Long-term results of Danish Prostatic Cancer Group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Commentary on maximal androgen blockade in prostate cancer: a theory to put into practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Worldwide activity and safety of bicalutamide: a summary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Single-agent therapy with bicalutamide: a comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Ocular toxicity of Anandron in patients treated for prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Nilutamide pneumonitis: a report on eight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Provocation test coupled with bronchoalveolar lavage in diagnosis of drug (nilutamide)-induced hypersensitivity pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Pulmonary complications of hormone treatment in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100112

10.1177/106002809703100112

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

8997470